Advertisement

Immunomodulation by Hepatitis B and Related Viruses

  • Mario R. Escobar
Part of the Infectious agents and pathogenesis book series (IAPA)

Abstract

Immunodeficiency disorders may occur as a result of one or more defects within the immune system spanning stem cell deficiencies, through immunoregulatory dysfunction, to a restricted failure to recognize or mount an immune response against certain antigens. The identification of these defects is complicated by their secondary effects, or by opportunistic infections in the immunocompromised host. Although the extent to which viral infections can initiate these deficits remains to be evaluated in most cases, the active role of many viruses in inducing immunosuppression is well established.

Keywords

Chronic Hepatitis Viral Hepatitis Acquire Immune Deficiency Syndrome Chronic Active Hepatitis Chronic Viral Hepatitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Blum, H. E., L. Stowring, A. Figus, C. K. Montgomery, A. T. Haase, and G. N. Vyas. Detection of hepatitis B virus DNA in hepatocytes, bile duct epithelium, and vascular elements by in situ hybridization, Proc. Natl Acad. Sci. USA 80:6682–6685 (1983).Google Scholar
  2. 2.
    Chong-Jin, O. and D. Jenk-Ling, Hepatitis B virus in lymphocytes of seronegative car riers, Lancet 1:395–396 (1984).CrossRefGoogle Scholar
  3. 3.
    Laure, F., D. Zagury, A. G. Saimot, R. C. Gallo, B. H. Hahn, and C. Brechot, Hepatitis B virus DNA sequences in lymphoid cells from patients with AIDS and AIDS-related complex, Science 229:561–563 (1985).PubMedCrossRefGoogle Scholar
  4. 4.
    Lie-Injo, L. E., M. Balasegaram, C. G. Lopez, and A. R. Herrera, Hepatitis B viral DNA in liver and white blood cells of patients with hepatoma, DNA 2:301–308 (1983).PubMedCrossRefGoogle Scholar
  5. 5.
    Pontisso, P., M. C. Poon, P. Tiollais, and C. Brechot, Detection of hepatitis B virus DNA in mononuclear blood cells, Br. Med. J. 288:1563–1566 (1984).CrossRefGoogle Scholar
  6. 6.
    Romet-Lemonne, J. L., E. Elfassi, W. Haseltine, and M. Essex, Infection of bone marrow cells by hepatitis B virus, Lancet 2:732 (1983).PubMedCrossRefGoogle Scholar
  7. 7.
    Romet-Lemonne, J. L., M. F. McLane, E. Elfassi, W. Haseltine, J. Azocar, and M. Essex, Hepatitis B virus infection in cultured human lymphoblastoid cells, Science 221:667–669 (1983).PubMedCrossRefGoogle Scholar
  8. 8.
    Summers, J. and W. Mason, Replication of the genome of a hepatitis B-like virus by reverse transcriptase of an RNA intermediate, Cell 29:403–415 (1982).PubMedCrossRefGoogle Scholar
  9. 9.
    Korba, B. E., F. Wells, B. C. Tennat, G. H. Yoakum, R. H. Purcell and J. L. Gerin, Hepadnavirus infection of peripheral blood lymphocytes in vivo: Woodchuck and chimpanzee models of viral hepatitis,/. Virol. 58:1–8 (1986).PubMedGoogle Scholar
  10. 10.
    Melnick, J. L., Classification of hepatitis A virus as enterovirus type 72 and hepatitis B as a hepadnavirus type 1, Intervirology 18:105–106 (1982).PubMedCrossRefGoogle Scholar
  11. 11.
    Robinson, W. S., P. Marion, M. Feitelson, and A. Siddiqui, The hepadnavirus group: Hepatitis B and related viruses, in: Viral Hepatitis ,1981 International Symposium (W. Szmuness, H. J. Alter, and J. E. Maynard, eds.), pp. 57–68, Franklin Institute Press, Philadelphia (1982).Google Scholar
  12. 12.
    Summers, J., J. Smolec, and R. Snyder, A virus similar to hepatitis B associated with hepatitis and hepatoma in woodchucks, Proc. Natl. Acad. Sci. USA 75:4523–4537 (1978).CrossRefGoogle Scholar
  13. 13.
    Marion, P. L., L. S. Oshiro, D. C. Regnery, G. H. Scullard, and W. S. Robinson, A virus in Beechy ground squirrels that is related to hepatitis B virus of humans, Proc. Natl. Acad. Sci. USA 77:2941–2945 (1980).PubMedCrossRefGoogle Scholar
  14. 14.
    Mason, W. S., G. Seal, and J. Summers, Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus, J. Virol. 35:829–836 (1980).Google Scholar
  15. 15.
    Cote, P. J., Jr., G. M. Dapolito, J. W-K. Shin, and J. L. Gerin, Surface antigenic determi nants of mammalian “hepadnavirus” defined by group and class-specific monoclonal antibodies,/. Virol. 3:135–142 (1982).Google Scholar
  16. 16.
    Howard, C. R., The nature of the hepatitis B virus and its mode of replication, Springer Semin. Immunopathol. 3:397–419 (1981).PubMedCrossRefGoogle Scholar
  17. 17.
    Chernesky, M. A., M. R. Escobar, P. D. Swenson, and S. Specter, Laboratory diagnosis of hepatitis viruses, Cumitech 18:1–12 (1984).Google Scholar
  18. 18.
    LeBouvier, G. L., The heterogeneity of Australia antigen, J. Infect. Dis. 123:671–675 (1971).CrossRefGoogle Scholar
  19. 19.
    Bancroft, W. A., F. F. Mundon, and P. K. Russel, Detection of additional antigenic determinants of hepatitis B antigen, J. Immunol. 109:842–848 (1972).PubMedGoogle Scholar
  20. 20.
    Heermann, K. H., U. Goldman, W. Schwartz, T. Seyffarth, H. Baumgarten, and W. H. Gerlich, Large surface proteins of hepatitis B virus containing the pre-S sequence, J. Virol. 52:396–401 (1984).PubMedGoogle Scholar
  21. 21.
    Stibbe, W. and W. H. Gerlich, Variable protein composition of hepatitis B surface antigen from different donors, Virology 123:436–442 (1982).PubMedCrossRefGoogle Scholar
  22. 22.
    Tiollais, P, P. Charnay, and G. N. Vyas, Biology of hepatitis B virus, Science 213:406–411 (1981).PubMedCrossRefGoogle Scholar
  23. 23.
    Machida, A., S. Kishimoto, H. Ohnuma, K. Baba, Y. Ito, H. Miyamoto, G. Funatsu, K. Oda, S. Usuda, S. Togami, T. Nakamura, M. Miyakawa, and M. Mayumi, A polypeptide containing 55 amino acid residues coded by the pre-S region of hepatitis B virus deoxyribonucleic acid bears the receptor for polymerized human as well as chimpanzee albumins, Gastroenterology 86:910–918 (1984).PubMedGoogle Scholar
  24. 24.
    Stibbe, W. and W. H. Gerlich, Structural relationships between minor and major proteins of hepatitis B surface antigen, J. Virol. 46:626–628 (1983).PubMedGoogle Scholar
  25. 25.
    Takahashi, K., Y. Akahane, T. Gotanda, T. Mishiro, M. Imai, Y. Miyakawa, and N. Mayumi, Demonstration of hepatitis B e antigen in the core of Dane particles, J. Immunol. 122:275–279 (1979).PubMedGoogle Scholar
  26. 26.
    Yoshizawa, H., Y. Itoh, J. P. Simonetti, T. Takahashi, A. Machida, Y. Miyakawa, and M. Mayumi, Demonstration of hepatitis B e antigen in hepatitis B core particles obtained from the nucleus of hepatocytes infected with hepatitis B virus, J. Gen. Virol. 42:513–519 (1979).PubMedCrossRefGoogle Scholar
  27. 27.
    Murphy, B., E. Tabor, V. McAuliffe, A. Williams, J. Maynard, R. Gerety, and R. Purcell, Third component, HBeAg/3, of hepatitis B e antigen system identified by the different double diffusion techniques,/. Clin. Microbiol. 8:349–350 (1978).PubMedGoogle Scholar
  28. 28.
    Williams, A. and G. L. LeBouvier, Heterogeneity and thermolability of “e” antigen, Bibl. Haematol. 42:71–75 (1976).PubMedGoogle Scholar
  29. 29.
    Imai, M., M. Nomura, T. Gotanda, T. Sano, K. Tachibana, H. Miyamoto, K. Takahashi, S. Toyama, Y. Miyakawa, and M. Mayumi, Demonstration of two distinct antigenic determinants on hepatitis B e antigen by monoclonal antibodies, J. Immunol. 128:69–72 (1982).PubMedGoogle Scholar
  30. 30.
    Summers, J., Replication of hepatitis B viruses, in Viral Hepatitis and Liver Disease (G. N. Vyas, J. L. Dienstag, and J. H. Hoofnagle, eds.), pp. 87–96, Grune &Stratton, Orlando, Florida (1984).Google Scholar
  31. 31.
    Escobar, M. R. and P. D. Swenson, Mechanisms of viral immunopathology with special reference to viral hepatitis, in Immunomodulation by Microbial Products and Related Synthetic Compounds (Y. Yamamura, S. Kotani, I. Azuma, A. Koda, and T. Shiba, eds.), pp. 134–147, Excerpta Medica, Amsterdam (1982).Google Scholar
  32. 32.
    Blumberg, B. S., Comments on the biology of HBV, in Viral Hepatitis (G. N. Vyas, S. N. Cohen, and R. Schmid, eds.), pp. 591–592, The Franklin Institute Press, Philadelphia (1978).Google Scholar
  33. 33.
    Walker, M. E., W. Szmuness, C. Stevens, and P. Rubenstein, Genetics of anti-HBs responsiveness. I. HLA-DR7 and nonresponsiveness to hepatitis vaccination, Transfusion 21:601 (1981) (abst.).Google Scholar
  34. 34.
    Milich, D. R., H. Alexander, and F. V. Chisari, Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). III. Circumvention of nonrespon siveness in mice bearing HBsAg nonresponder haplotypes, J. Immunol. 130:1401–1407 (1983).PubMedGoogle Scholar
  35. 35.
    Milich, D. R. and F. V. Chisari, Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). I. H-2 restriction of the murine humoral immune response to a and d determinants of HBsAg, J. Immunol. 129:320–325 (1982).PubMedGoogle Scholar
  36. 36.
    Milich, D. R., G. G. Leroux-Roels, and F. V. Chisari, Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). II. Qualitative characteristics of the humoral immune response to the a, d ,and y determinants of HBsAg, J. Immunol. 130:1395–1400 (1983).PubMedGoogle Scholar
  37. 37.
    Szmuness, W., C. E. Stevens, E. A. Zang, E. J. Harley, and A. Kellner. A control clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): A final report, Hepatology 1:377–385 (1981).PubMedCrossRefGoogle Scholar
  38. 38.
    Montano, L., G. C. Miescher, A. H. Goodall, K. H. Wiedmann, G. Janossy, and H. C. Thomas, Hepatitis B virus and HLA antigen display in the liver during chronic hepatitis B virus infection, Hepatology 2:557–561 (1982).PubMedCrossRefGoogle Scholar
  39. 39.
    Dienstag, J. L., Immunologic mechanisms in chronic viral hepatitis, in Viral Hepatitis and Liver Disease (G. N. Vyas, J. L. Dienstag, and J. H. Hoofnagle, eds.), pp. 135–166, Grune &Stratton, Orlando (1984).Google Scholar
  40. 40.
    Craxi, A., L. Montano, A. Goodall, and H. C. Thomas, Genetic and sex-linked factors influencing HBs antigen clearance. I. Nonimmune clearance in inbred strains of mice, J. Med. Virol. 9:117–123 (1982).PubMedCrossRefGoogle Scholar
  41. 41.
    Klingenstein, R.J. and J. L. Dienstag, Immunopathogenesis of acute and chronic hepatitis B, in Hepatitis B (R. J. Gerety, ed.), pp. 221–245, Academic, Orlando (1985).Google Scholar
  42. 42.
    Smith, C. I., W. G. E. Cooksley, and L. W. Powell, Cell-mediated immunity to liver antigen in toxic liver injury. I. Occurrence and specificity, Clin. Exp. Immunol. 39:607–617 (1980).PubMedGoogle Scholar
  43. 43.
    Smith, C. I., W. G. E. Cooksley, and L. W. Powell, Cell-mediated immunity to liver antigen in toxic liver injury. II. Role in pathogenesis of liver damage, Clin. Exp. Immunol. 39:618–625 (1980).PubMedGoogle Scholar
  44. 44.
    Blumberg, B. S., H. I. Sutnick, and W. T. London, Australia antigen as a hepatitis virus. Variation in host response. Am. J. Med. 48:1–8 (1970).PubMedCrossRefGoogle Scholar
  45. 45.
    Dudley, F. J., R. A. Fox, and S. Sherlock, Cellular immunity and hepatitis-associated Australia antigen in liver disease, Lancet 1:723–726 (1972).PubMedCrossRefGoogle Scholar
  46. 46.
    Serjeantson, S., and D. G. Woodfìeld, Immune response of leprosy patients to hepatitis B virus, Am. J. Epidemiol. 107:321–327 (1978).PubMedGoogle Scholar
  47. 47.
    Chisari, F. V., J. A. Routenberg, D. S. Anderson, and T. S. Edgington, Cellular immune reactivity in HBV-induced disease, in: Viral Hepatitis (G. N. Vyas, S. N. Cohen, and R. Schmid, eds.), pp. 245–266, Franklin Institute Press, Philadelphia (1978).Google Scholar
  48. 48.
    Dusheiko, G. M., J. H. Hoofnagle, W. G. Cooksley, S. P. James, and E. A. Jones, Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepati tis B surface antigen carriers, J. Clin. Invest. 71:1104–1113 (1983).PubMedCrossRefGoogle Scholar
  49. 49.
    Chisari, F. V., and T. S. Edgington, Lymphocyte E rosette inhibitory factor: A regulatory serum lipoprotein, J. Exp. Med. 142:1092–1107 (1975).PubMedCrossRefGoogle Scholar
  50. 50.
    Celis, E., P. C. Kung, and T. W. Chang, Hepatitis B virus-reactive human T lymphocyte clones: Antigen specificity and helper function for antibody synthesis, J. Immunol. 132:1511–1516 (1984).PubMedGoogle Scholar
  51. 51.
    Hellstrom, U., and S. Sylvan, Regulation of the immune response to hepatitis B virus and human serum albumin. I. Hepatitis B surface antigen-induced secretion of antibodies with specificity for human serum albumin in hepatitis B-immune donors in vitro, Scand.J. Immunol. 23:545–553 (1986).PubMedCrossRefGoogle Scholar
  52. 52.
    Kerlin, P., K. M. Nies, and M. J. Tong, Unimpaired B-cell function and T-cell regulation of immunoglobulin synthesis in patients with chronic hepatitis B virus infection, Clin. Immunol. Immunopathol. 25:149–156 (1982).PubMedCrossRefGoogle Scholar
  53. 53.
    Vento, S., J. E. Hegarty, A. Alberti, C. J. O’Brien, G. J. M. Alexander, A. L. W. F. Eddleston, and R. Williams, T-lymphocyte sensitization to HBcAg and T-cell mediated unresponsiveness to HBsAg in hepatitis B virus-related chronic liver disease, Hepatology 5:192–197 (1985).PubMedCrossRefGoogle Scholar
  54. 54.
    Milich, D. R., G. B. Thornton, A. R. Neurath, S. B. Kent, M -L. Michel, P. Tiollais, and F. V. Chisari, Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen, Science 228:1195–1198 (1985).PubMedCrossRefGoogle Scholar
  55. 55.
    Milich, D. R., A. McLachlan, F. V. Chisari, S. B. H. Kent, and G. B. Thornton, Immune response to the pre-S(l) region of the hepatitis B surface antigen (HBsAg): A pre-S(1) specific T cell response can bypass nonresponsiveness to the pre-S(2) and S regions of HBsAg, J. Immunol. 137:315–322 (1986).PubMedGoogle Scholar
  56. 56.
    McAuliffe, V. J., R. H. Purcell, and J. L. Gerin, Type B hepatitis: A review of current prospects for a safe and effective vaccine, Rev. Infect. Dis. 2:470–492 (1980).PubMedCrossRefGoogle Scholar
  57. 57.
    Melnick, J. L., G. R. Dreesman, and F. B. Hollinger, Approaching the control of viral hepatitis type B, J. Infect. Dis. 133:210–229 (1976).PubMedCrossRefGoogle Scholar
  58. 58.
    Thomas, H. C., and D. P.Jewell, Acute and chronic viral hepatitis, in: Clinical Gastrointestinal Immunology (H. C. Thomas and D. P.Jewell, eds.), pp. 164–210, Blackwell Scientific Publications, London (1979).Google Scholar
  59. 59.
    Fathman, C. G., and F. W. Fitch (eds.), Isolation, Characterization and Utilization of T Lymphocyte Clones ,Academic, New York (1982).Google Scholar
  60. 60.
    Pernis, B. and H. J. Vogel, Regulatory T. Lymphocytes ,Academic, New York (1980).Google Scholar
  61. 61.
    Roberts, I. M., C. C. Bernard, G. N. Vyas, and I. R. MacKay, T-cell dependence of immune response to hepatitis B antigen in mice, Nature (Lond.) 254:606–607 (1975).CrossRefGoogle Scholar
  62. 62.
    Tabor, E., R. J. Gerety, L. A. Smallwood, and L. F. Barker, Coincident hepatitis B surface antigen and antibodies of different subtypes in human serum, J. Immunol. 118:369–370 (1977).PubMedGoogle Scholar
  63. 63.
    Lane, H. C., G. Whalen, and A. S. Fauci, Dichotomy between antigen and mitogen-induced T cell help in human B cell activation, Clin. Res. 30:252 (1982) (abst.).Google Scholar
  64. 64.
    Machida, A., S. Kishimoto, H. Ohnuma, H. Miyamoto, K. Baba, K. Oda, T. Nakamura, Y. Miyakawa, and M. Mayumi, A hepatitis B surface antigen polypeptide (p31) with the receptor for polymerized human as well as chimpanzee albumins, Gastroenterology 85:268–274 (1983).PubMedGoogle Scholar
  65. 65.
    Okamoto, H., M. Imai, S. Usuda, E. Tanaka, K. Tachibana, S. Mishiro, A. Machida, T. Nakamura, Y. Miyakawa, and M. Mayumi, Hemagglutination assay of polypeptide coded by the pre-S region of hepatitis B virus DNA with monoclonal antibody: Correlation of pre-S polypeptide with the receptor for polymerized human albumin in serums containing hepatitis B antigens, J. Immunol. 134:1212–1216 (1985).PubMedGoogle Scholar
  66. 66.
    Okamoto, H. S. Usuda, M. Imai, K. Tachibana, E. Tanaka, T. Kumakura, M. Itabashi, E. Takai, F. Tsuda, T. Nakamura, Y. Miyakawa, and M. Mayumi, Antibody to the receptor for polymerized human serum albumin in acute and persistent infection with hepatitis B virus, Hepatology 6:354–359 (1986).PubMedCrossRefGoogle Scholar
  67. 67.
    Yu, M. W., J. S. Finlayson, and J. W-K. Shih, Interaction between various polymerized human albumins and hepatitis B surface antigen, J. Virol. 55:736–743 (1985).PubMedGoogle Scholar
  68. 68.
    Neurath, A. R., S. B. H. Kent, N. Strick, and K. Parker, Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus, Cell 46:429–436 (1986).PubMedCrossRefGoogle Scholar
  69. 69.
    Gold, J. W. M., H. J. Alter, P. V. Holland, J. L. Gerin, and R. H. Purcell, Passive hemagglutination assay for antibody to subtypes of hepatitis B surface antigen, J. Immu nol. 112:1100–1106 (1974).Google Scholar
  70. 70.
    Markenson, J. A., R.J. Gerety, J. H. Hoofnagle, and L. F. Barker, Effect of a cyclophosphamide on hepatitis B virus infection and challenge on chimpanzees, J. Infect. Dis. 131:79–87 (1975).PubMedCrossRefGoogle Scholar
  71. 71.
    Swenson, P. D., M. R. Escobar, R. L. Carithers, and T. J. Sobieski III, Failure of preexistent antibody against hepatitis B surface antigen to prevent subsequent hepatitis B infection, J. Clin. Microbiol. 18:305–309 (1983).PubMedGoogle Scholar
  72. 72.
    Troisi, C. L. and F. B. Hollinger, Detection of an IgM antiidiotype directed against anti-HBs in hepatitis B patients, Hepatology 5:758–762 (1985).PubMedCrossRefGoogle Scholar
  73. 73.
    Tabor, E. and R. J. Gerety, Possible role of immune responses to hepatitis B core antigen in protection against hepatitis B infection. (Letter.), Lancet 1:172 (1984).PubMedCrossRefGoogle Scholar
  74. 74.
    Goudeau, A. and F. Dubois, Immune status of anti-HBc positive individuals, Lancet 1:396 (1984).PubMedCrossRefGoogle Scholar
  75. 75.
    Goudeau, A., F. Dubois, F. Barin, M. D. Dubois, and P. Coursaget, Hepatitis B vaccine: Clinical trials in high-risk settings in France. (September 1975-September 1982), Dev. Biol. Std. 54:267–284 (1983).Google Scholar
  76. 76.
    Brechot, C., M. Hadchouel, J. Scotto, M. Fonck, F. Potet, G. N. Vyas, and P. Tiollais, State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and -negative liver diseases, Proc. Natl. Acad. Sci. USA 78:3906–3910 (1981).PubMedCrossRefGoogle Scholar
  77. 77.
    Katchaki, J. N., R. Brouwer, and T. H. Siem, Anti-HBc and blood, N. Engl. J. Med. ,298:1421–1422 (1978).PubMedCrossRefGoogle Scholar
  78. 78.
    Hellstrom, U. and S. Sylvan, Editorial Reviews: Human serum albumin and the enigma of chronic hepatitis type B, Scand. J. Immunol. 23:523–527 (1986).PubMedCrossRefGoogle Scholar
  79. 79.
    Fakunle, Y. M., F. Aranguibel, D. De Villiers, H. C. Thomas, and S. Sherlock, Monomeric (7S) IgM in chronic liver disease, Clin. Exp. Immunol. 38:204–210 (1979).PubMedGoogle Scholar
  80. 80.
    Sjogren, M. and J. H. Hoofnagle, Immunoglobulin M antibody to hepatitis B core antigen in patients with chronic type B hepatitis, Gastroenterology 89:252–258 (1985).PubMedGoogle Scholar
  81. 81.
    Trevisan, A., G. Realdi, A. Alberti, G. Ongaro, E. Pornaro, and R. Meliconi, Core antigen-specific immunoglobulin G bound to the liver cell membrane in chronic hepatitis B, Gastroenterology 82:218–222 (1982).PubMedGoogle Scholar
  82. 82.
    Pape, G. R., E. P. Rieber, J. Eisenburg, R. Hoffman, C. M. Balch, G. Baumgartner, and G. Riethmuller, Involvement of the cytotoxic/suppressor T-cell subset in liver diseases, Gastroenterology 85:657–662 (1983).PubMedGoogle Scholar
  83. 83.
    Nouri-Aria, K. T., G. J. M. Alexander, B. Portmann, D. Vergani, A. L. W. F. Eddleston, and R. Williams, In vitro study of IgG production and concanavalin A induced suppressor cell function in acute and chronic hepatitis B virus infection, Clin. Exp. Immunol. 64:50–58 (1986).PubMedGoogle Scholar
  84. 84.
    Klingenstein, R. J., A. M. Savarese, J. L. Dienstag, R. H. Rubin, and A. K. Bahn, Immunoregulatory T cell subsets in acute and chronic hepatitis, Hepatology 1:523 (1981) (abst.).Google Scholar
  85. 85.
    Thomas, H. C., D. Brown, G. Routhier, G. Janossy, P. C. Kung, G. Goldstein, and S. Sherlock, Inducer and suppressor T-cells in hepatitis B virus-induced liver disease, Hepatology 2:202–204 (1982).PubMedCrossRefGoogle Scholar
  86. 86.
    Dienstag, J. L. Immunopathogenesis of acute and chronic hepatitis B, in: Hepatitis B (R. J. Gerety, ed.), pp. 221–245, Academic, Orlando, Florida (1985).Google Scholar
  87. 87.
    Barnaba, V., A. Musca, C. Cordova, M. Levrero, G. Ruocco, V. Albertini-Petroni, and F. Balsano, Relationship between T cell subsets and suppressor cell activity in chronic hepatitis B virus (HBV) infection, Clin. Exp. Immunol. 53:281–288 (1983).PubMedGoogle Scholar
  88. 88.
    Hodgson, H. J. F., J. R. Wands, and K. J. Isselbacher, Alteration in suppressor cell activity in chronic active hepatitis, Proc. Natl. Acad. Sci. USA 75:1549–1553 (1978).PubMedCrossRefGoogle Scholar
  89. 89.
    Pignata, C., P. Vajro, R. Troncone, G. Monaco, and M. Ciriaco, Immunoregulatory T subsets in chronic active viral hepatitis: Characterization by monoclonal antibodies,/. Pediatr. Gastroenterol. Nutr. 2:229–233 (1983).PubMedGoogle Scholar
  90. 90.
    Alexander, G. J. M., M. Mondelli, N. V. Naumov, K. T. Nouri-Aria, D. Vergani, D. Lowe, A. L. W. F. Eddleston, and R. Williams, Functional characterization of peripheral blood lymphocytes in chronic HBsAg carriers, Clin. Exp. Immunol. 63:498–507 (1986).PubMedGoogle Scholar
  91. 91.
    Rubin, R. H., W. P. Carney, R. T. Schooley, R. B. Colbin, R. C. Burton, R. A. Hoffman, W. P. Harrsen, A. B. Cosimi, P. S. Russell, and M. S. Hirsch, The effect of infection on T-lymphocyte subpopulations: A preliminary report, Int. J. Immunopharmacol. 3:307–312 (1981).PubMedCrossRefGoogle Scholar
  92. 92.
    Mallucci, L. and B. Edwards, Influence of the cytoskeleton on the expression of a mouse hepatitis virus (MHV-3) in peritoneal macrophages: Acute and persistent infection, J. Gen. Virol 63:217–221 (1982).PubMedCrossRefGoogle Scholar
  93. 93.
    Chisari, F. V. Regulation of lymphocyte function and viral transformation by hepatic bioregulatory molecules, Hepatology 2:97–106s (1982).Google Scholar
  94. 94.
    Levy, G. A., and F. V. Chisari, The immunopathogenesis of chronic HBV induced liver disease, Spnger Semin. Immunopathol. 3:439–459 (1981).CrossRefGoogle Scholar
  95. 95.
    Berg, P. A., N. W. Brattig, and W. Grauer, Immunoregulatory serum factors in acute and chronic hepatitis, Liver 2:275–278 (1982).Google Scholar
  96. 96.
    Brattig, N. W., and P. A. Berg, Serum inhibitory factors (SIF) in patients with acute and chronic hepatitis and their clinical significance, Clin. Exp. Immunol. 25:40–49 (1976).PubMedGoogle Scholar
  97. 97.
    Sanders, G. and R. P. Perillo, Rosette inhibitory factor: T-lymphocyte subpopulation specificity and potential immunoregulatory role in hepatitis B virus infection, Hepatology 2:547–552 (1982).PubMedCrossRefGoogle Scholar
  98. 98.
    Grauer, W., N. W. Brattig, H. Schomerus, G. Frosner, and P. A. Berg, Immunosup pressive serum factors in viral hepatitis. III. Prognostic relevance of rosette inhibitory factor and serum inhibitory factor in acute and chronic hepatitis, Hepatology 4:15–19 (1984).PubMedCrossRefGoogle Scholar
  99. 99.
    Brattig, N. W., G. E. Schrempf-Dekker, C. W. Brockl, and P. A. Berg, Immunosuppressive serum factors in viral hepatitis. II. Further characterization of serum inhibition factor as an albumin-associated molecule, Hepatology 3:647–655 (1983).PubMedCrossRefGoogle Scholar
  100. 100.
    Hill, D. A., J. H. Walsh, and R. H. Purcell, Failure to demonstrate circulating interferon during incubation period and acute stage of transfusion-associated hepatitis, Proc. Soc. Exp. Biol. Med. 136:853–856 (1971).PubMedGoogle Scholar
  101. 101.
    Levin, S., and T. Hahn, Interferon system in acute viral hepatitis, Lancet 1:592–594 (1982).PubMedCrossRefGoogle Scholar
  102. 102.
    Tolentino, P., F. Dianzani, M. Zucca, and R. Giacchino, Decreased interferon response by lymphocytes from children with chronic hepatitis, J. Infect. Dis. 132:459–461 (1975).PubMedCrossRefGoogle Scholar
  103. 103.
    Yousefi, S., M. R. Escobar, and R. L. Carithers, Immune interferon induction: A measure of cellular immune deficiency in hepatitis B carriers, Hepatology 3:826 (1983) (abst.).Google Scholar
  104. 104.
    Pirovino, M., M. Aguet, M. Huber, J. Altorfer, and M. Schmid, Absence of detectable serum interferon in acute and chronic viral hepatitis, Hepatology 6:645–647 (1986).PubMedCrossRefGoogle Scholar
  105. 105.
    Kato, Y., H. Nakgawa, K. Kobayashi, N. Hattori, and K. Hatano, Interferon production by peripheral lymphocytes in HBsAg-positive liver diseases, Hepatology 2:789–790 (1982).PubMedCrossRefGoogle Scholar
  106. 106.
    Davis, G. L., J. L. Jicha, and J. H. Hoofnagle, Alpha and gamma interferon in patients with chronic type B, non-A, non-B, and delta hepatitis: Serum levels and in vitro produc tion by lymphocytes, Gastroenterology 86:1315 (1984) (abst.).Google Scholar
  107. 107.
    Anderson, R. E., W. Winkelstein, Jr., H. E. Blum, and G. N. Vyas, Hepatitis B virus infection in the acquired immunodeficiency syndrome (AIDS), in: Viral Hepatitis and Liver Disease (G. N. Vyas, J. L. Dienstag, and J. H. Hoofnagle, eds.), pp. 339–343, Grune &Stratton, Orlando, Florida (1984).Google Scholar
  108. 108.
    McDonald, M. I., J. D. Hamilton, and D. T. Durack, Hepatitis B surface antigen could harbor the infectious agent of AIDS, Lancet 2:882–884 (1983).PubMedCrossRefGoogle Scholar
  109. 109.
    Ravenholt, R. T., Role of hepatitis B virus in acquired immunodeficiency syndrome, Lancet 2:885–886 (1983).PubMedCrossRefGoogle Scholar
  110. 110.
    Taylor, P. E., C. E. Stevens, S. Rodriguez de Cordoba, and P. Rubinstein, Hepatitis B virus and human immunodeficiency virus: Possible interaction, in: Viral Hepatitis and Liver Disease (A.J. Zuckerman, ed.), pp. 198–200, Alan R. Liss, Inc., New York (1988).Google Scholar
  111. 111.
    Govindarajan, S., V. M. Edwards, M. L. Stuart, E. A. Operskalski, J. W. Mosley, and The Transfusion Safety Study Group, Influence of human immunodeficiency virus infection on expression of chronic hepatitis B and D virus infections, in: Viral Hepatitis and Liver Disease (A. J. Zuckerman ed.), pp. 201–204, Alan R. Liss, Inc., New York (1988).Google Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • Mario R. Escobar
    • 1
  1. 1.Department of PathologyMedical College of VirginiaRichmondUSA

Personalised recommendations